American Journal of Cardiology
Volume 102, Issue 3 , Pages 257-265 , 1 August 2008

Comparison of Value of Leads from Body Surface Maps to 12-Lead Electrocardiogram for Diagnosis of Acute Myocardial Infarction

Received 21 January 2008 ,Revised 17 March 2008 ,Accepted 17 March 2008.

References 

  1. McClelland AJ, Owens CG, Menown IB, Lown M, Adgey AA. Comparison of the 80-lead body surface map to physician and to 12-lead electrocardiogram in detection of acute myocardial infarction. Am J Cardiol. 2003;92:252–257
  2. Owens CG, McClelland AJ, Walsh SJ, Smith BA, Tomlin A, Riddell JW, et al. Pre-hospital 80-lead mapping: does it add significantly to the diagnosis of acute coronary syndromes?. J Electrocardiol. 2004;37(suppl):223–232
  3. Maynard SJ, Menown IB, Manoharan G, Allen J, Anderson J, Adgey AA. Body surface mapping improves early diagnosis of acute myocardial infarction in patients with chest pain and left bundle branch block. Heart. 2003;89:998–1002
  4. Menown IB, Allen J, Anderson JMcC, Adgey AA. ST depression only on the initial 12-lead ECG: early diagnosis of acute myocardial infarction. Eur Heart J. 2001;22:218–227
  5. Menown IBA, Mackenzie G, Adgey AAJ. Optimizing the initial 12-lead electrocardiographic diagnosis of acute myocardial infarction. Eur Heart J. 2000;21:275–283
  6. Macfarlane PW, Browne D, Devine B, Clark E, Miller E, Seyal J, et al. Modification of ACC/ESC criteria for acute myocardial infarction. J Electrocardiol. 2004;37(suppl):98–103
  7. Taher T, Fu Y, Wagner GS, Goodman SG, Fresco C, Granger CB, et al. Aborted myocardial infarction in patients with ST-segment elevation insights from the assessment of the safety and efficacy of a new thrombolytic regimen-3 trial electrocardiographic substudy. J Am Coll Cardiol. 2004;44:38–43
  8. Wallentin L, Goldstein P, Armstrong PW, Granger CB, Adgey AA, Arntz HR, et al. Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction. Circulation. 2003;108:135–142
  9. O'Keefe JH, Sayed-Taha K, Gibson W, Christian TF, Bateman TM, Gibbons RJ. Do patients with left circumflex coronary artery–related acute myocardial infarction without ST-segment elevation benefit from reperfusion therapy?. Am J Cardiol. 1995;75:718–720
  10. O'Keefe JH, Gibbons RJ. Left circumflex occlusion—underrecognized and undertreated. J Thromb Thrombolysis. 2000;10:221–225
  11. Matetzky S, Freimark D, Feinberg MS, Novikov I, Rath S, Rabinowitz B, et al. Acute myocardial infarction with isolated ST-segment elevation in posterior chest leads V7-9: “hidden” ST-segment elevations revealing acute posterior infarction. J Am Coll Cardiol. 1999;34:748–753
  12. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). http://www.acc.org/clinical/guidelines/unstable/unstable.pdf
  13. Ripa RS, Holmvang L, Maynard C, Sejersten M, Clemmensen P, Grande P, et al. Consideration of the total ST-segment deviation on the initial electrocardiogram for predicting final acute posterior myocardial infarct size in patients with maximum ST-segment deviation as depression in leads V1 through V3 (A FRISC II substudy). J Electrocardiol. 2005;38:180–186
  14. Barrabes JA, Figueras J, Moure C, Cortadellas J, Soler-Soler J. Prognostic significance of ST segment depression in lateral leads I, aVL, V5 and V6 on the admission electrocardiogram in patients with a first acute myocardial infarction without ST segment elevation. J Am Coll Cardiol. 2000;35:1813–1819
  15. Barrabes JA, Figueras J, Moure C, Cortadellas J, Soler-Soler J. Prognostic value of lead aVR in patients with a first non–ST-segment elevation acute myocardial infarction. Circulation. 2003;108:814–819

 Dr. McClelland and Dr. Walsh received research grants from the Research and Development Office, Belfast, Northern Ireland. Dr. Owens received funding from the Frances and Augustus Newman Foundation, United Kingdom.

PII: S0002-9149(08)00559-6

doi: 10.1016/j.amjcard.2008.03.046

American Journal of Cardiology
Volume 102, Issue 3 , Pages 257-265 , 1 August 2008

Article Tools

* Image Usage & Resolution